Citadel Advisors - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$4,198,040
-54.6%
36,190
-54.0%
0.00%
-100.0%
Q2 2023$9,237,971
-15.4%
78,688
-42.3%
0.00%0.0%
Q1 2023$10,922,186
+43.5%
136,425
+42.0%
0.00%
+100.0%
Q4 2022$7,611,141
+218.1%
96,076
+179.8%
0.00%
Q3 2022$2,393,000
-1.5%
34,338
-7.2%
0.00%
Q2 2022$2,429,000
-3.8%
37,000
-2.5%
0.00%
Q1 2022$2,524,000
-77.3%
37,932
-76.2%
0.00%
-100.0%
Q4 2021$11,139,000
+115.5%
159,245
+60.8%
0.00%
+200.0%
Q3 2021$5,170,000
+204.1%
99,003
+296.0%
0.00%
Q2 2021$1,700,000
+116.3%
25,000
+145.1%
0.00%
Q1 2021$786,000
-65.1%
10,200
-72.8%
0.00%
Q4 2020$2,251,000
+115.8%
37,508
+54.8%
0.00%
Q3 2020$1,043,000
+16.4%
24,224
+12.0%
0.00%
Q2 2020$896,000
-96.2%
21,629
-96.0%
0.00%
-100.0%
Q1 2020$23,423,000
-21.2%
541,702
+0.9%
0.01%
-15.4%
Q4 2019$29,731,000
+59.1%
536,847
-0.3%
0.01%
+44.4%
Q3 2019$18,690,000
-6.6%
538,226
+8.3%
0.01%0.0%
Q2 2019$20,021,000
+88.5%
497,170
+54.0%
0.01%
+80.0%
Q1 2019$10,623,000
+52.6%
322,874
-3.6%
0.01%
+25.0%
Q4 2018$6,961,000335,0290.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 771,250$53,949,0004.15%
First Light Asset Management, LLC 680,170$47,578,0003.41%
ACT CAPITAL MANAGEMENT, LLC 59,000$4,127,0002.98%
S Squared Technology, LLC 95,215$6,660,0002.98%
Redmile Group, LLC 1,820,898$127,372,0002.90%
Soleus Capital Management, L.P. 228,437$15,979,0001.60%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 50,922$3,562,0001.59%
Artal Group S.A. 700,000$48,965,0001.33%
SILVERARC CAPITAL MANAGEMENT, LLC 46,670$3,265,0001.32%
Kynam Capital Management, LP 34,816$2,435,0001.30%
View complete list of KRYSTAL BIOTECH INC shareholders